Standard BioTools
LAB
107 hedge funds and large institutions have $750M invested in Standard BioTools in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 22 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 27
33% more call options, than puts
Call options by funds: $3.03M | Put options by funds: $2.29M
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
3% more funds holding
Funds holding: 104 → 107 (+3)
42% less capital invested
Capital invested by funds: $1.29B → $750M (-$538M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$18.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$15.4M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$14.5M |
| 4 |
Millennium Management
New York
|
+$10.9M |
| 5 |
Primecap Management
Pasadena,
California
|
+$10.8M |
Top Sellers
LAB Hedge Fund Activity: Q2 2015 in Review
107 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2015, worth a combined $750M — down 42% from $1.29B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new LAB positions and 22 closed out — a net gain of 4 holders — while 48 added to existing stakes and 27 trimmed.
The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $18.9M. The largest seller was Next Century Growth Investors, exiting entirely with an estimated $56.9M sold.
- 107 institutional investors held Standard BioTools (LAB) as of Q2 2015, up from 104 in Q1 2015.
- Funds reported $750M of Standard BioTools stock for Q2 2015, down 42% quarter-over-quarter.
- 26 funds opened new Standard BioTools positions in Q2 2015 and 22 closed out, a net change of +4 holders.
- The largest Standard BioTools buyer in Q2 2015 was EverPoint Asset Management, an estimated $18.9M added.
- The largest Standard BioTools seller in Q2 2015 was Next Century Growth Investors, an estimated $56.9M sold.
Based on aggregated 13F filings for Q2 2015.